Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Current standards of neuropsychological assessment in epilepsy surgery centers across Europe.

Vogt VL, Äikiä M, Del Barrio A, Boon P, Borbély C, Bran E, Braun K, Carette E, Clark M, Cross JH, Dimova P, Fabo D, Foroglou N, Francione S, Gersamia A, Gil-Nagel A, Guekht A, Harrison S, Hecimovic H, Heminghyt E, Hirsch E, Javurkova A, Kälviäinen R, Kavan N, Kelemen A, Kimiskidis VK, Kirschner M, Kleitz C, Kobulashvili T, Kosmidis MH, Kurtish SY, Lesourd M, Ljunggren S, Lossius MI, Malmgren K, Mameniskiené R, Martin-Sanfilippo P, Marusic P, Miatton M, Özkara Ç, Pelle F, Rubboli G, Rudebeck S, Ryvlin P, van Schooneveld M, Schmid E, Schmidt PM, Seeck M, Steinhoff BJ, Shavel-Jessop S, Tarta-Arsene O, Trinka E, Viggedal G, Wendling AS, Witt JA, Helmstaedter C; E-PILEPSY consortium.

Epilepsia. 2017 Mar;58(3):343-355. doi: 10.1111/epi.13646. Epub 2017 Jan 9.

PMID:
28067423
2.

Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years.

Cohen MJ, Meador KJ, Browning N, May R, Baker GA, Clayton-Smith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW; NEAD study group.

Epilepsy Behav. 2013 Nov;29(2):308-15. doi: 10.1016/j.yebeh.2013.08.001. Epub 2013 Sep 5.

3.

Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.

Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW; NEAD Study Group.

Lancet Neurol. 2013 Mar;12(3):244-52. doi: 10.1016/S1474-4422(12)70323-X. Epub 2013 Jan 23.

4.

Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years.

Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW; NEAD Study Group.

Neurology. 2012 Apr 17;78(16):1207-14. doi: 10.1212/WNL.0b013e318250d824. Epub 2012 Apr 4. Erratum in: Neurology. 2012 May 15;78(20):1622.

5.

Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age.

Meador KJ, Baker GA, Browning N, Cohen MJ, Clayton-Smith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW; NEAD Study Group.

Brain. 2011 Feb;134(Pt 2):396-404. doi: 10.1093/brain/awq352. Epub 2011 Jan 11.

6.

Effects of breastfeeding in children of women taking antiepileptic drugs.

Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW; NEAD Study Group.

Neurology. 2010 Nov 30;75(22):1954-60. doi: 10.1212/WNL.0b013e3181ffe4a9. Epub 2010 Nov 24.

7.

Antiepileptic drug use in women of childbearing age.

Meador KJ, Penovich P, Baker GA, Pennell PB, Bromfield E, Pack A, Liporace JD, Sam M, Kalayjian LA, Thurman DJ, Moore E, Loring DW; NEAD Study Group.

Epilepsy Behav. 2009 Jul;15(3):339-43. doi: 10.1016/j.yebeh.2009.04.026. Epub 2009 May 27.

8.

Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs.

Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW; NEAD Study Group.

N Engl J Med. 2009 Apr 16;360(16):1597-605. doi: 10.1056/NEJMoa0803531.

Supplemental Content

Loading ...
Support Center